Ticker Symbol: IRWD
Ironwood Pharmaceuticals Inc - Class A
$12.30 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001446847
Company Profile
Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 100 Summer St Ste 2300
Website: www.ironwoodpharma.com
CEO: Mark Mallon
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $9.69
Change:
$0.46
(
4.98%)
Days Range: $9.19 - $9.77
Beta: 0.58
52wk. High: $12.66
52wk. Low: $8.07
Ytd. Change -20.45%
50 Day Moving Average: $9.21
200 Day Moving Average: $10.19
Shares Outstanding: 156029186
Valuation
Market Cap: 151.3B
PE Ratio: -1.88
EPS (TTM): -5.15
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A